These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 23128910)
1. Old and new antirheumatic drugs and the risk of hepatotoxicity. Anelli MG; Scioscia C; Grattagliano I; Lapadula G Ther Drug Monit; 2012 Dec; 34(6):622-8. PubMed ID: 23128910 [TBL] [Abstract][Full Text] [Related]
2. Hepatotoxicity related to antirheumatic drugs. Aithal GP Nat Rev Rheumatol; 2011 Mar; 7(3):139-50. PubMed ID: 21263458 [TBL] [Abstract][Full Text] [Related]
3. Hepatotoxicity of antirheumatic drugs. Tolman KG J Rheumatol Suppl; 1990 May; 22():6-11. PubMed ID: 2192059 [TBL] [Abstract][Full Text] [Related]
4. [Methotrexate, liver and rheumatoid arthritis in tropical areas]. Diouf ML; Diallo S; Mbengue M; Moreira-Diop T Sante; 2001; 11(3):195-200. PubMed ID: 11641084 [TBL] [Abstract][Full Text] [Related]
6. Risk of hepatotoxicity with add-on leflunomide in rheumatoid arthritis patients. Gupta R; Bhatia J; Gupta SK Arzneimittelforschung; 2011; 61(5):312-6. PubMed ID: 21755815 [TBL] [Abstract][Full Text] [Related]
7. Drug-Induced Gastrointestinal and Hepatic Disease Associated with Biologics and Nonbiologic Disease-Modifying Antirheumatic Drugs. Wood PR; Caplan L Rheum Dis Clin North Am; 2018 Feb; 44(1):29-43. PubMed ID: 29149926 [TBL] [Abstract][Full Text] [Related]
8. Newer disease-modifying antirheumatic drugs and the risk of serious hepatic adverse events in patients with rheumatoid arthritis. Suissa S; Ernst P; Hudson M; Bitton A; Kezouh A Am J Med; 2004 Jul; 117(2):87-92. PubMed ID: 15234643 [TBL] [Abstract][Full Text] [Related]
9. Liver injury from nonsteroidal anti-inflammatory drugs in the United States. Schmeltzer PA; Kosinski AS; Kleiner DE; Hoofnagle JH; Stolz A; Fontana RJ; Russo MW; Liver Int; 2016 Apr; 36(4):603-9. PubMed ID: 26601797 [TBL] [Abstract][Full Text] [Related]